High Outlier
Strength
50 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093206506
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
CILOSTAZOLApproval Type
Generic (ANDA)
FDA Application
ANDA077027On Market Since
4/24/2012
Pharmacological Classes
Phosphodiesterase 3 Inhibitor
Phosphodiesterase 3 Inhibitors
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
CILOSTAZOL 50 MG TABLET
Generic
50268017615•AvPAK
$0.1162
per EA
CILOSTAZOL 50 MG TABLET
Generic
60505252101•Apotex Corp.
$0.1162
per EA
CILOSTAZOL 50 MG TABLET
Generic
70436015606•Slate Run Pharmaceuticals LLC
$0.1162
per EA
CILOSTAZOL 100 MG TABLET
Generic
50268017715•AvPAK
$0.1287
per EA
CILOSTAZOL 100 MG TABLET
Generic
60505252201•Apotex Corp.
$0.1287
per EA
CILOSTAZOL 100 MG TABLET
Generic
70436015706•Slate Run Pharmaceuticals LLC
$0.1287
per EA
ANAGRELIDE HCL 0.5 MG CAPSULE
Generic
13668045301•Torrent Pharmaceuticals Limited
$0.7265
per EA
ANAGRELIDE HCL 0.5 MG CAPSULE
Generic
62135031212•Chartwell RX LLC
$0.7265
per EA
ANAGRELIDE HCL 0.5 MG CAPSULE
Generic
70954087910•ANI Pharmaceuticals, Inc.
$0.7265
per EA
ANAGRELIDE HCL 1 MG CAPSULE
Generic
13668046201•Torrent Pharmaceuticals Limited
$1.5333
per EA